Director and Head of Investor Relations
Phone - Direct: +46 8 587 254 15
As pioneers of future technology, Elekta is setting a new standard of cancer care once again with magnetic resonance radiation therapy (MR/RT).
MR/RT addresses an unmet need in cancer therapy, enabling clinicians to confidently see and track difficult to visualize soft-tissue anatomies.
The Elekta share has been listed on the OMX Nordic Exchange (earlier Stockholm Stock Exchange) since 1994 under the ticker EKTAb. The share is included in the Large Cap segment and the sector Health Care Equipment
Head of Investor Relations (interim)
Executive Vice President, Corporate Communications & IR